Skip to main content
. 2016 Jun 16;18:141. doi: 10.1186/s13075-016-1040-z

Fig. 3.

Fig. 3

C-Col10 was significantly higher in patients with axial spondyloarthritis (axSpA) naïve to biological treatment than in those currently or formerly treated with biologic DMARDs. The same trend was observed in patients with psoriatic arthritis (PsA), though it did not reach statistical significance. Error bars are shown as SEM. Student’s t test was applied to compare the two groups. *p < 0.05. ns not significant